Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK.
Saved in:
| Title: | Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK. |
|---|---|
| Authors: | McCrimmon, Rory J.1 (AUTHOR), Falla, Edel2 (AUTHOR), Sha, Jo Zhou2 (AUTHOR), Alsaleh, Abdul Jabbar Omar3 (AUTHOR), Lew, Elisheva4 (AUTHOR) Elisheva.Lew@sanofi.com, Hudson, Richard5 (AUTHOR), Baxter, Mike5 (AUTHOR), Palmer, Karen5 (AUTHOR) |
| Source: | Diabetes Therapy. Dec2021, Vol. 12 Issue 12, p3217-3230. 14p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
